ScholarIQanswers from OpenAlex
Parkinson's UK
InstitutionResearch output, impact & collaborations
Parkinson's UK is a institution indexed in ScholarIQ from OpenAlex.
What is known about Parkinson's UK?
ScholarIQrecord summary
Parkinson's UK is a research organisation in London, GB. OpenAlex records 1,043 works and 213,243 citations for it. 284 researchers list it as their most recent affiliation.
How many works does Parkinson's UK have?
ScholarIQindexed works
Parkinson's UK has 1,043 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Parkinson's UK have?
ScholarIQcitation count
Parkinson's UK has 213,243 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Parkinson's UK?
ScholarIQresearcher count
Parkinson's UK has 284 researchers in the ScholarIQ index.
What is the average h-index at Parkinson's UK?
ScholarIQavg h-index
Parkinson's UK has an average h-index of 59.5 in OpenAlex.
What is the ROR of Parkinson's UK?
ScholarIQror
The ROR for Parkinson's UK is on the source record.
What is the OpenAlex record for Parkinson's UK?
ScholarIQopenalex
The OpenAlex for Parkinson's UK is on the source record.
Who are the most-cited researchers behind Parkinson's UK?
ScholarIQtop researchers by citations
What are the most-cited papers on Parkinson's UK?
ScholarIQmost cited works
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk
Julio Rosenstock, Vlado Perkovic, Odd Erik Johansen, Mark E. Cooper, Steven E. Kahn, Nikolaus Marx, John H. Alexander, Michael Pencina, Robert D. Toto, Christoph Wanner, Bernard Zinman, Hans J. Woerle, David Baanstra, Egon Pfarr, Sven Schnaidt, Thomas Meinicke, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, for the CARMELINA Investigators
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi, Bernard Zinman, David Fitchett, Christoph Wanner, Ele Ferrannini, Martin Schumacher, Claudia Schmoor, Kristin Ohneberg, Odd Erik Johansen, Jyothis T. George, Stefan Hantel, Erich Bluhmki, John M. Lachin
Effect of Linagliptin vs Glimepiride on Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes
Julio Rosenstock, Steven E. Kahn, Odd Erik Johansen, Bernard Zinman, Mark A. Espeland, Hans J. Woerle, Egon Pfarr, Annett Keller, Michaela Mattheus, David Baanstra, Thomas Meinicke, Jyothis T. George, Maximilian von Eynatten, Darren K. McGuire, Nikolaus Marx, for the CAROLINA Investigators
The kisspeptin-GnRH pathway in human reproductive health and disease
Karolina Skorupskaite, Jyothis T. George, Richard A. Anderson
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
Christoph Wanner, John M. Lachin, Silvio E. Inzucchi, David Fitchett, Michaela Mattheus, Jyothis T. George, Hans J. Woerle, Uli C. Broedl, Maximilian von Eynatten, Bernard Zinman
How much of the research on Parkinson's UK is open access?
ScholarIQopen access share
82%OPEN ACCESS